AwesomeCapital
Search This Blog
Thursday, June 13, 2019
Bristol-Myers target cut to $51 from $55 by UBS
Maintains Neutral
https://www.benzinga.com/stock/BMY/ratings
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.